Recently, the Class 1.1 innovative traditional Chinese medicine (TCM) Xiao' er Huangjin Zhike Granules of Beijing Dongfang Yunjia Pharmaceutical Co., Ltd. is approved for marketing through the priority review and approval procedure by China NMPA.

This product has the functions of clearing the lung, resolving phlegm, and suppressing cough by purifying lung qi, and is indicated for the treatment of cough caused by mild acute bronchitis with phlegm-heat obstructing the lung syndrome in children, characterized by clinical manifestations including red tongue with thin yellow or yellow greasy coating. The marketing of this TCM provides new treatment options for children with mild acute bronchitis.